Drotrecogin alfa (activated) in sepsis: Initial experience with patient selection, cost, and clinical outcomes.All Scholarly Works
Document TypeArticle, Peer-reviewed
AbstractDuring a 1-year period, the authors examined clinical experience with drotrecogin alfa, activated for sepsis in a 24-bed medical-surgical intensive care unit. Drotrecogin alfa, activated was administered 46 times to 44 patients (3% of all intensive care u
Citation InformationJ Intensive Care Med. 2005 Nov-Dec;20(6):339-45.